Xencor, Inc. (XNCR)
26.06
-2.82
(-9.76%)
USD |
NASDAQ |
Aug 28, 16:00
26.05
-0.01
(-0.04%)
Pre-Market: 20:00
Xencor Price to Book Value : 3.849 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 3.849 |
| August 27, 2026 | 4.266 |
| August 26, 2026 | 4.201 |
| August 25, 2026 | 4.328 |
| August 24, 2026 | 4.283 |
| August 21, 2026 | 4.106 |
| August 20, 2026 | 3.988 |
| August 19, 2026 | 4.065 |
| August 18, 2026 | 3.753 |
| August 17, 2026 | 3.415 |
| August 14, 2026 | 3.447 |
| August 13, 2026 | 3.396 |
| August 12, 2026 | 3.424 |
| August 11, 2026 | 3.264 |
| August 10, 2026 | 3.188 |
| August 07, 2026 | 3.074 |
| August 06, 2026 | 2.954 |
| August 05, 2026 | 2.930 |
| August 04, 2026 | 2.942 |
| August 03, 2026 | 2.866 |
| July 31, 2026 | 2.985 |
| July 30, 2026 | 3.174 |
| July 29, 2026 | 2.885 |
| July 28, 2026 | 2.950 |
| July 27, 2026 | 2.933 |
| Date | Value |
|---|---|
| July 24, 2026 | 2.871 |
| July 23, 2026 | 2.885 |
| July 22, 2026 | 2.882 |
| July 21, 2026 | 3.021 |
| July 20, 2026 | 2.778 |
| July 17, 2026 | 2.580 |
| July 16, 2026 | 2.208 |
| July 15, 2026 | 2.213 |
| July 14, 2026 | 2.208 |
| July 13, 2026 | 2.210 |
| July 10, 2026 | 2.341 |
| July 09, 2026 | 2.380 |
| July 08, 2026 | 2.431 |
| July 07, 2026 | 2.314 |
| July 06, 2026 | 2.199 |
| July 02, 2026 | 2.216 |
| July 01, 2026 | 2.272 |
| June 30, 2026 | 2.378 |
| June 29, 2026 | 2.241 |
| June 26, 2026 | 2.162 |
| June 25, 2026 | 2.117 |
| June 24, 2026 | 2.076 |
| June 23, 2026 | 2.022 |
| June 22, 2026 | 2.012 |
| June 18, 2026 | 1.816 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Incyte Corp. | 3.940 |
| Regeneron Pharmaceuticals, Inc. | 2.590 |
| MacroGenics, Inc. | 6.131 |
| UroGen Pharma Ltd. | -- |
| MeiraGTx Holdings Plc | 6.038 |
Price to Book Value Related Metrics
| PS Ratio | 18.63 |
| Price | 26.06 |
| Earnings Yield | -8.33% |
| Market Cap | 1.937B |